|
|
|
ÀÌ°æÇØ ( Lee Kyung-Hae ) - ¿¬¼¼ÀÇ·á¿ø
½Å°æ¹Î ( Shin Kyung-Min ) - ¿¬¼¼ÀÇ·á¿ø ÀÌÇöÁ¤ ( Lee Hyeon-Jeong ) - ¿¬¼¼ÀÇ·á¿ø ±è¼Ò¿µ ( Kim So-Young ) - ¿¬¼¼ÀÇ·á¿ø äÁ¤¿ø ( Chae Jung-Won ) - ¿¬¼¼ÀÇ·á¿ø ±è¹Ì¶ó ( Kim Mi-Ra ) - ¿¬¼¼ÀÇ·á¿ø Çѹοµ ( Han Min-Young ) - ¿¬¼¼ÀÇ·á¿ø ¾È¹Ì¼÷ ( Ahn Mi-Sook ) - ¿¬¼¼ÀÇ·á¿ø ¹ÚÁø°æ ( Park Jin-Kyung ) - ¿¬¼¼ÀÇ·á¿ø Á¤¹Ì¾Ö ( Chung Mi-Ae ) - ¿¬¼¼ÀÇ·á¿ø Ãß»óÈñ ( Chu Sang-Hui ) - ¿¬¼¼´ëÇб³ °£È£´ëÇРȲÁ¤È ( Hwang Jung-Hwa ) - ¿¬¼¼ÀÇ·á¿ø
|
|
Abstract
|
|
|
|
Purpose: This study was to develop evidence-based clinical practice guideline in order to prevent contrastinduced
nephropathy (CIN) for patients undergoing percutaneous coronary intervention (PCI).
Methods: The guideline was developed based on the "Scottish Intercollegiate Guidelines Network (SIGN)". The first draft of
guideline was developed through 5 stages and evaluated by 10 experts.(1) Clinical questions were ensured in PICO format.(2) Two researchers conducted a systematic search through electronic database, identifying 170 studies. We selected 27 full text articles including 16 randomized clinical trials, 7 systematic reviews, and 4 guidelines. Quality of each studies were evaluated by the Cochran¡¯s Risk of Bias, AMSTAR, K-AGREEII. Among the studies, 11 studies were excluded.(3) The strength of recommendations were classified and quality of recommendations were ranked.(4) Guideline draft was finalized.(5) Content-validation was conducted by an expert group. All contents were ranked above 0.8 in CVI.
Results: Evidence-based clinical practice guideline to prevent CIN was dveloped.(1) The guideline for preventing CIN recommends using 0.9% saline.(2) Standardized rate of fluid therapy is 1 to 1.5ml/kg/hr.(3) Execute hydration for 6~12hrs before PCI and after PCI.
Conclusion: This study suggests evidence-based clinical practice guideline for preventing CIN which can be more efficiently used in clinical practice.
|
|
KeyWords
|
|
Contrast Media, Acute Kidney Injury, Evidence-Based Practice, Fluid Therapy
|
|
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
|
|
|
|
µîÀçÀú³Î Á¤º¸
|
|
|
|
|
|